Neil Stahl - EVP Research and Development, Regeneron Pharmaceuticals, Inc

As of December 14, 2021


Neil Stahl Net Worth

  • Net worth is estimated to be at least $122.29M
  • Owns at least 33,414 units of Regeneron Pharmaceuticals, Inc stock
  • Sold an estimated value of $311.04M in the last 18 years at Regeneron Pharmaceuticals, Inc

Neil Stahl Trading

  • Largest purchase of shares was 52,500 units , worth over $7.82M on May 18, 2021
  • Largest sale of shares was 101,000 units , worth over $56.5M on November 9, 2015
  • In total has made about 60 transactions over 18 years
  • Usually trades in December, with the busiest year in 2020, 2012 and 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Regeneron Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

Regeneron Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 10,000 units sold on May 18, 2022 by Andrew Murphy worth over $6.54M
  • In the last 19 years, insiders at Regeneron Pharmaceuticals, Inc sold an estimated value of $17.26B and bought an estimated value of $3.4B
  • The most active traders are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director
  • Insider trading is most common in December, with the busiest year in 2014

REGENERON PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1